Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact:
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026

Recent News Articles

December 30, 2015

A bill to fund two programs that support treatment derived from adult stem cells through 2020 has been approved by Congress and signed by President Barack Obama.

The Stem Cell Therapeutic and Research Reauthorization Act received bipartisan support in both houses. The measure funds the C.W. Bill Young Cell Transplantation Program for five years at $30 million annually, while the National Cord Blood Inventory is authorized at $23 million annually for a 5 year period.

December 4, 2015

For the second year in a row, BioBridge Global will be serving as an organizing sponsor of the World Stem Cell Summit. The 2015 summit is next week in Atlanta.

Executives from BBG will be participating in multiple sessions at the event, which is coordinated by the Genetic Policy Institute and runs Dec. 10-12. BioBridge Global was an organizing sponsor of the 2014 summit, which was in San Antonio.

BBG subsidiary QualTex Laboratories operates a major facility in the Atlanta metro area.

November 23, 2015

A bill has been introduced in the U.S. House of Representatives that would allow parents to use funds from a health savings account or flexible spending account to pay for the collection and storage of umbilical cord blood in a private bank.

Sponsored by U.S. Reps. Erik Paulsen (R-Minn.) and Ron Kind (D-Wis.), the Family Cord Blood Banking Act would allow use of pre-tax HSA or FSA funds to pay for the collection and storage of the stem cell-rich cord blood.

Cord blood banking currently is not an authorized expense for either of the accounts, which are designed to help pay for healthcare not covered by insurance.

“After the birth of a child, parents are often immediately faced with a decision of whether to have blood and tissue collected and stored in case of future illness,” Paulsen said.

November 9, 2015

Every month is marrow awareness month for Luis Lopez.

Lopez, who received the Awareness Award from the National Marrow Donor Program last week, has been an advocate for bone marrow donor registration since his daughter Lily was diagnosed with acute lymphoblastic leukemia in 2011.

He worked tirelessly to find a matching donor for his daughter, since a bone marrow transplant plays a critical role in the treatment of blood cancers. However, the one match generated from the Be The Match registry was unable to donate.

Lily died in 2014, but Luis’ efforts continue. He works closely with staff from the GenCure Marrow Donor Program on recruitment for the Be The Match registry, and he is serving as the keynote speaker at the GenCure Marrow Donor Program’s Donor Appreciation Dinner on Friday, Nov. 13.

October 26, 2015

One of the latest studies in the ever-growing field of stem-cell therapy will begin later this year at the University of Pittsburgh, as researchers look into regenerating the main blood vessel in the body.

Bioengineers at Pitt’s Swanson School of Engineering will be looking into ways to use stem cells to restore and regenerate the aorta. A weakening and enlargement of the aorta – known as an abdominal aortic aneurysm (AAA) – can rupture, causing life-threatening bleeding.

Ruptured abdominal aortic aneurysms are responsible for 10,000 deaths a year in the United States.